Published in Drug Saf on February 01, 2014
Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case-control study. BMC Psychiatry (2015) 1.44
Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ (2015) 1.10
Differential expression of 5-HT-related genes in symptomatic pulmonary embolism patients. Int J Clin Exp Med (2015) 0.79
Theoretical and practical issues related to the management of severe and refractory psychotic illness complicated by pulmonary embolism. Indian J Psychiatry (2016) 0.75
Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis. Br J Clin Pharmacol (2016) 0.75
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72
Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol (2006) 3.30
Suicide, depression, and antidepressants. BMJ (2005) 2.88
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ (2009) 2.25
Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management. J Head Trauma Rehabil (2015) 1.96
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry (2011) 1.89
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry (2013) 1.80
EMA must improve the quality of its clinical trial reports. BMJ (2011) 1.78
Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull (2008) 1.70
Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev (2015) 1.58
Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev (2014) 1.56
Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol (2005) 1.30
Selective serotonin reuptake inhibitors. BMJ (2004) 1.28
Venlafaxine for major depression. BMJ (2007) 1.20
Long-term treatment of depression with antidepressants: a systematic narrative review. Can J Psychiatry (2007) 1.20
"Wish bias" in antidepressant drug trials? J Clin Psychopharmacol (2004) 1.17
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry (2008) 1.04
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis. Stat Med (2012) 0.98
Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (2011) 0.98
Seven criteria for improving effectiveness trials in psychiatry. Psychol Med (2006) 0.94
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. Eur J Clin Pharmacol (2012) 0.92
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol (2006) 0.90
Publication bias in systematic reviews. Arch Gen Psychiatry (2007) 0.89
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev (2015) 0.89
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med (2014) 0.88
Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2010) 0.88
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol (2007) 0.88
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios. Stat Med (2014) 0.87
Depressive disorders. Clin Evid (2004) 0.87
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther (2010) 0.87
Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr (2013) 0.86
Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev (2009) 0.86
Paroxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2014) 0.86
[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr Res (2012) 0.86
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy. Soc Psychiatry Psychiatr Epidemiol (2005) 0.84
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. J Clin Psychopharmacol (2011) 0.84
Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis. Clin Trials (2013) 0.84
Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol (2009) 0.84
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. Evid Based Ment Health (2008) 0.83
Validity of the impact factor of journals as a measure of randomized controlled trial quality. J Clin Psychiatry (2006) 0.82
International dosage differences in fluoxetine clinical trials. Can J Psychiatry (2005) 0.82
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. CNS Drugs (2008) 0.82
Randomized trials published in Chinese or Western journals: comparative empirical analysis. J Clin Psychopharmacol (2012) 0.81
Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2013) 0.80
Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Br J Clin Pharmacol (2007) 0.80
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia. Eur Neuropsychopharmacol (2013) 0.80
Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev (2010) 0.79
Risk of suicidal behaviour in adults taking antidepressants. BMJ (2009) 0.79
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review. Mini Rev Med Chem (2008) 0.79
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. Riv Psichiatr (2012) 0.79
Azapirones versus placebo for panic disorder in adults. Cochrane Database Syst Rev (2014) 0.78
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. Atherosclerosis (2011) 0.78
Depression in adults: drug and physical treatments. BMJ Clin Evid (2007) 0.78
Agomelatine and the brave old world of narrative-based medicine. Evid Based Ment Health (2012) 0.78
CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation? Psychopharmacology (Berl) (2006) 0.78
Assessing risk of bias in randomized controlled trials. Epidemiol Psichiatr Soc (2011) 0.78
Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma. Ann Intern Med (2016) 0.77
Implementation of treatment guidelines for specialist mental health care. Schizophr Bull (2014) 0.77
Time to abandon Evidence Based Medicine? Evid Based Ment Health (2013) 0.77
Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev (2015) 0.77
Antidepressants and benzodiazepines for panic disorder in adults. Cochrane Database Syst Rev (2016) 0.77
Efficacy of antipsychotic drugs for schizophrenia - Authors' reply. Lancet (2013) 0.76
Ethnic differences in the utilization of mental health services in Lombardy (Italy): an epidemiological analysis. Soc Psychiatry Psychiatr Epidemiol (2014) 0.76
Validity of indirect comparisons in meta-analysis. Lancet (2007) 0.76
Treatment choices in women with bipolar disorder seeking pregnancy: a clinical case illustration. Case Rep Psychiatry (2013) 0.76
Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy. Psychiatr Serv (2011) 0.76
Review: maintenance antidepressants reduce risk of relapse but effect is not as great in recurrent depression. Evid Based Ment Health (2009) 0.76
Explanatory and pragmatic trials. Epidemiol Psichiatr Soc (2007) 0.76
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression. Evid Based Ment Health (2009) 0.75
Choice of data extraction tools for systematic reviews depends on resources and review complexity. J Clin Epidemiol (2009) 0.75
Novel melatonin-based treatments for major depression. Lancet (2012) 0.75
Cognitive improvements with antipsychotics: real or practice effect? Evid Based Ment Health (2008) 0.75
Depressive disorder needs an evidence base commensurate with its public health importance. Can J Psychiatry (2007) 0.75
Review: is aripiprazole as effective as risperidone in people with schizophrenia? Evid Based Ment Health (2010) 0.75
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial. BMC Res Notes (2014) 0.75
Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects. Evid Based Ment Health (2007) 0.75
Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health (2009) 0.75
Conventional vs. atypical antipsychotic medications. N Engl J Med (2006) 0.75
Nulla dies sine linea. Evid Based Ment Health (2014) 0.75
Outcome reporting bias in clinical trials. Epidemiol Psichiatr Soc (2009) 0.75
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach. Epidemiol Psichiatr Soc (2008) 0.75
Depression in adults. Clin Evid (2006) 0.75
Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Pathological Features and Scheduled Pharmacological Therapies. J Head Trauma Rehabil (2016) 0.75
Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials. Int Clin Psychopharmacol (2017) 0.75
Depressive disorders. Am Fam Physician (2006) 0.75